Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: Results of a phase II trial

Clinical Breast Cancer

Volumn 4, Issue 1, 2003, Pages 46-50

  Lobo, F ^a   Virizuela, J A ^b   Dorta, F J ^c   Florian J ^d   Lomas, M ^e   Jimenez E ^b   Lopez P ^c   Casado, V ^a   Leon A ^a   Esteves L G ^a   Domine M ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b HOSPITAL DE JEREZ   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d HOSPITAL DE BARBASTRO   (Spain)

^e HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Combination chemotherapy; Taxanes

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTIMITOTIC AGENT; CYTARABINE; GEMCITABINE; NAVELBINE; RECOMBINANT GROWTH FACTOR; TAXANE DERIVATIVE;

ADULT; AGED; ALOPECIA; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHENIA; BLOOD TOXICITY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; EXPERIMENTAL DESIGN; FEBRILE NEUTROPENIA; FEMALE; FEVER; HORMONAL THERAPY; HUMAN; INFECTION; INFECTIOUS PNEUMONIA; METASTASIS; NAUSEA AND VOMITING; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PHLEBITIS; POPULATION RESEARCH; PROGNOSIS; SKIN TOXICITY; STOMATITIS; THROMBOCYTOPENIA; TREATMENT FAILURE;

EID: 12444302839     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2003.n.011     Document Type: Article

References (18)

1. Winer EP, Morrow M, Osborne CK, et al. Malignant tumors of the breast. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:1651-1717.
2. Giordano SH, Buzdar AU, Kau SWC, et al. Improvement in breast cancer survival: results from M. D. Anderson Cancer Center protocols from 1975-2000. Proc Am Soc Clin Oncol 2002; 21:54a (Abstract #212).
3. Hertel LW, Boder GB, Kroin JS, et al. Evaluation of the antitumor activity of gemcitabine (2', 2'-difluoro-2'-deoxycytidine). Cancer Res 1990; 50:4417-4422.
4. Budman DR. Vinorelbine: a third generation vinca alkaloid. Cancer Invest 1997; 15:475-490.
5. Binet S, Chaineau E, Fellous A, et al. Immunofluorescence study of the action of Navelbine, vincristine, and vinblastine on mitotic and axonal microtubules. Int J Cancer 1990; 46:262-266.
6. Seidman AW. Gemcitabine as single-agent therapy in the management of advanced breast cancer. Oncology 2001; 15(suppl 3):11-14.
7. Marty M, Extra JM, Dieras V, et al. A review of the antitumor activity of vinorelbine in breast cancer. Drugs 1992; 44(suppl 4):9-35.
8. Hortobagyi GN. Future directions for vinorelbine. Semin Oncol 1995; 22(suppl 5):80-87.
9. Fumoleau P, Delozier T, Extra JM, et al. Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience. Semin Oncol 1995; 22(suppl 5):22-29.
10. Lorusso V, Carpagnano F, Di Rienzo G, et al. Combination of gemcitabine and vinorelbine in non-small cell lung cancer (NSCLC). A phase I-II study. Proc Am Soc Clin Oncol 1997; 16:453a (Abstract #1628).
11. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47:207-214.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
13. Haider K, Kornek G, Kwansy W, et al. Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor. Breast Cancer Res Treat 1999; 55:203-211.
14. Valenza R, Leonardi V, Gebbia V, et al. Gemcitabine and vinorelbine in pretreated advanced breast cancer: a pilot study. Ann Oncol 2000; 11:495-496.
15. Nicolaides C, Dimopoulos MA, Samantas E, et al. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 2000; 11:873-875.
16. Sanal SM, Gokmen E, Karabulut B, et al. Gemcitabine and vinorelbine combination in patients with metastatic breast cancer. Breast J 2002; 8:171-176.
17. Stathopoulos GP, Rigatos SK, Pergantas N, et al. Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer. J Clin Oncol 2002; 20:37-41.
18. Mariani G, Tagliabue P, Zucchinelli P, et al. Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer. Breast Cancer Res Treat 2001; 70:163-169.